Plerixafor hydrochloride is a hematopoietic stem cell mobilizer classified as a bicyclam derivative that functions as an antagonist of the CXCR4 receptor and an allosteric agonist of CXCR7. By disrupting… Read more
Plerixafor hydrochloride is a hematopoietic stem cell mobilizer classified as a bicyclam derivative that functions as an antagonist of the CXCR4 receptor and an allosteric agonist of CXCR7. By disrupting the binding of CXCR4 to its ligand, this agent facilitates the release of stem cells from the bone marrow, supporting collection for transplantation procedures. The associated collection of reference standards includes the active pharmaceutical ingredient, its pharmacopeial and non-pharmacopeial impurities, and stable isotope-labelled compounds. These materials are essential for pharmaceutical laboratories conducting rigorous analytical testing, including impurity profiling and method validation. Using these high-quality standards, researchers can accurately identify and quantify related substances and metabolites during quality control processes, ensuring compliance with regulatory requirements for pharmaceutical manufacturing and development.